| NCT03375515 |
PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain |
https://ClinicalTrials.gov/show/NCT03375515 |
Recruiting |
Fujian Cancer Hospital |
2020-12-31 |
| NCT03374592 |
Volumetric Intensity Modulated Arc Therapy vs. Conventional Radiotherapy for Cancer Pain |
https://ClinicalTrials.gov/show/NCT03374592 |
Completed |
Centre hospitalier de l’Université de Montréal (CHUM) |
2017-12-20 |
| NCT03367637 |
A Novel mHealth Approach to Assess and Manage Palliative Care Needs for Cancer Patients in Kigali |
https://ClinicalTrials.gov/show/NCT03367637 |
Recruiting |
Massachusetts General Hospital |
2021-08-31 |
| NCT00805142 |
Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants |
https://ClinicalTrials.gov/show/NCT00805142 |
Completed |
Janssen Pharmaceutical K.K. |
2009-07-31 |
| NCT03362073 |
Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients |
https://ClinicalTrials.gov/show/NCT03362073 |
Recruiting |
Pusan National University Yangsan Hospital |
2019-12-31 |
| NCT03338543 |
PENS or TENS for Pain in Liver Cancer |
https://ClinicalTrials.gov/show/NCT03338543 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2018-04-30 |
| NCT03331055 |
PENS or TENS for Pain in Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT03331055 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2018-04-26 |
| NCT03226574 |
Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain |
https://ClinicalTrials.gov/show/NCT03226574 |
Active, not recruiting |
Sorrento Therapeutics, Inc. |
2020-03-18 |
| NCT03205579 |
Pain Education to Improve Cancer Pain Management Patients |
https://ClinicalTrials.gov/show/NCT03205579 |
Recruiting |
Mahidol University |
2019-06-30 |
| NCT03176121 |
Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain |
https://ClinicalTrials.gov/show/NCT03176121 |
Completed |
Taiwan Mundipharma Pharmaceuticals Ltd. |
2018-12-31 |
| NCT03146806 |
Intranasal (NAS) Ketamine for Cancer Pain |
https://ClinicalTrials.gov/show/NCT03146806 |
Completed |
Emory University |
2020-04-22 |
| NCT03031938 |
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies |
https://ClinicalTrials.gov/show/NCT03031938 |
Active, not recruiting |
Pfizer |
2022-04-04 |
| NCT02891785 |
Praxis Evaluation of a Pain Self-management Support Intervention for Oncology Patients: A Stepped Wedge Design Study |
https://ClinicalTrials.gov/show/NCT02891785 |
Completed |
University of Vienna |
2018-07-31 |
| NCT02791646 |
Optimizing Delivery of a Behavioral Cancer Pain Intervention Using a SMART |
https://ClinicalTrials.gov/show/NCT02791646 |
Recruiting |
Duke University |
2021-03-31 |
| NCT02783755 |
A mHealth Behavioral Cancer Pain Protocol for Medically Underserved Communities |
https://ClinicalTrials.gov/show/NCT02783755 |
Completed |
Duke University |
2017-06-30 |
| NCT02664350 |
Precision Medicine Guided Treatment for Cancer Pain |
https://ClinicalTrials.gov/show/NCT02664350 |
Completed |
University of Florida |
2019-01-10 |
| NCT02660229 |
An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion. |
https://ClinicalTrials.gov/show/NCT02660229 |
Completed |
Mundipharma Korea Ltd |
2016-07-31 |
| NCT02655289 |
Transcutaneous Electrical Nerve Stimulation (TENS) for Advanced Cancer Pain Patients |
https://ClinicalTrials.gov/show/NCT02655289 |
Completed |
University Hospital Freiburg |
2018-03-31 |
| NCT02609828 |
Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy. |
https://ClinicalTrials.gov/show/NCT02609828 |
Recruiting |
Pfizer |
2020-08-11 |
| NCT02345629 |
Cordotomy for Refractory Cancer Pain |
https://ClinicalTrials.gov/show/NCT02345629 |
Completed |
M.D. Anderson Cancer Center |
2020-02-25 |
| NCT02289261 |
A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain |
https://ClinicalTrials.gov/show/NCT02289261 |
Completed |
Cukurova University |
2015-02-28 |
| NCT02266017 |
Mobile Pain Coping Skills Training for Cancer Pain |
https://ClinicalTrials.gov/show/NCT02266017 |
Completed |
Duke University |
2018-03-21 |
| NCT01313234 |
Educational Intervention Targeting Nurses Attitudes and Knowledge About Cancer-related Pain Management |
https://ClinicalTrials.gov/show/NCT01313234 |
Completed |
Blekinge Institute of Technology |
2011-06-30 |
| NCT01968018 |
A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain |
https://ClinicalTrials.gov/show/NCT01968018 |
Completed |
Janssen-Cilag Ltd.,Thailand |
2007-04-30 |
| NCT01906073 |
Nasal Fentanyl for Chronic Cancer Pain |
https://ClinicalTrials.gov/show/NCT01906073 |
Recruiting |
Norwegian University of Science and Technology |
2020-11-30 |
| NCT01885182 |
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain |
https://ClinicalTrials.gov/show/NCT01885182 |
Completed |
Mundipharma (China) Pharmaceutical Co. Ltd |
2015-08-30 |
| NCT01809106 |
RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. |
https://ClinicalTrials.gov/show/NCT01809106 |
Completed |
Mario Negri Institute for Pharmacological Research |
2014-10-31 |
| NCT01719757 |
PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain |
https://ClinicalTrials.gov/show/NCT01719757 |
Completed |
Mundipharma Korea Ltd |
2013-10-31 |
| NCT01675622 |
Immediate-Release Oxycodone Capsules Study in Cancer Pain |
https://ClinicalTrials.gov/show/NCT01675622 |
Completed |
Mundipharma (China) Pharmaceutical Co. Ltd |
2012-06-30 |
| NCT01621100 |
Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients |
https://ClinicalTrials.gov/show/NCT01621100 |
Completed |
Janssen Korea, Ltd., Korea |
2012-09-30 |
| NCT01615653 |
EUS Guided Celiac Neurolysis |
https://ClinicalTrials.gov/show/NCT01615653 |
Completed |
Mayo Clinic |
2014-06-30 |
| NCT01589328 |
Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB |
https://ClinicalTrials.gov/show/NCT01589328 |
Completed |
National Cancer Center, Korea |
2017-06-30 |
| NCT01541124 |
Morphine as First Drug for Cancer Pain |
https://ClinicalTrials.gov/show/NCT01541124 |
Completed |
Federal University of São Paulo |
2011-06-30 |
| NCT01541111 |
Magnesium Associated With Morphine for Cancer Pain Relief |
https://ClinicalTrials.gov/show/NCT01541111 |
Completed |
Federal University of São Paulo |
2014-03-31 |
| NCT01493635 |
Two Step Versus the Standard Three Step Approach of the WHO Analgesic Ladder for Cancer Pain Relief. |
https://ClinicalTrials.gov/show/NCT01493635 |
Completed |
University of Edinburgh |
2016-03-31 |
| NCT01384877 |
Subcutaneous Lidocaine For Cancer-Related Pain |
https://ClinicalTrials.gov/show/NCT01384877 |
Completed |
British Columbia Cancer Agency |
2017-12-31 |
| NCT01337089 |
Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain |
https://ClinicalTrials.gov/show/NCT01337089 |
Completed |
GW Pharmaceuticals Ltd. |
2016-01-27 |
| NCT01326689 |
A Comparative Study of KW-2246 |
https://ClinicalTrials.gov/show/NCT01326689 |
Completed |
Kyowa Kirin Co., Ltd. |
2012-06-30 |
| NCT04436705 |
The Effectiveness of Progressive Muscle Relaxation Technique in Reducing Cancer-related Pain |
https://ClinicalTrials.gov/show/NCT04436705 |
Completed |
University of Jordan |
2016-09-30 |
| NCT04162379 |
Oral Prednisolone Effect on Cancer WHO Stepladder Analgesia Protocol |
https://ClinicalTrials.gov/show/NCT04162379 |
Completed |
Mansoura University |
2020-03-01 |
| NCT04125953 |
Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy |
https://ClinicalTrials.gov/show/NCT04125953 |
Recruiting |
Universitair Ziekenhuis Brussel |
2020-09-30 |
| NCT04095234 |
Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT) |
https://ClinicalTrials.gov/show/NCT04095234 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-09-30 |
| NCT04085120 |
Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain |
https://ClinicalTrials.gov/show/NCT04085120 |
Recruiting |
All India Institute of Medical Sciences, New Delhi |
2020-01-31 |
| NCT04040140 |
Integrating Auricular Point Acupressure Into Real-world Nursing Practice to Manage Cancer-related Pain |
https://ClinicalTrials.gov/show/NCT04040140 |
Recruiting |
Johns Hopkins University |
2021-04-30 |
| NCT03967327 |
A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain |
https://ClinicalTrials.gov/show/NCT03967327 |
Recruiting |
Mundipharma (China) Pharmaceutical Co. Ltd |
2020-12-20 |
| NCT03886298 |
Radiofrequency Splanchnic Denervation Versus Retrocrural Neurolytic Celiac Block for Pancreatic Cancer Pain |
https://ClinicalTrials.gov/show/NCT03886298 |
Recruiting |
Assiut University |
2020-04-10 |
| NCT03752268 |
Development of an Intervention to Enhance Cancer Pain Management |
https://ClinicalTrials.gov/show/NCT03752268 |
Recruiting |
Massachusetts General Hospital |
2020-11-30 |
| NCT03736746 |
Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals |
https://ClinicalTrials.gov/show/NCT03736746 |
Completed |
Dana-Farber Cancer Institute |
2019-08-02 |
| NCT03669263 |
A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan |
https://ClinicalTrials.gov/show/NCT03669263 |
Completed |
Chang Gung Memorial Hospital |
2016-06-23 |
| NCT03606811 |
Fluoroscopic &Ultrasonographic Guidance of Superior Hypogastric Plexus Neurolysis in Intractable Pelvic Pain |
https://ClinicalTrials.gov/show/NCT03606811 |
Completed |
Assiut University |
2019-08-01 |
| NCT03597737 |
Utility of an APP for the Monitoring of Irruptive Oncological Pain |
https://ClinicalTrials.gov/show/NCT03597737 |
Active, not recruiting |
Universitat Jaume I |
2019-03-28 |
| NCT03558594 |
Hypnosis and Meditation for Cancer Pain |
https://ClinicalTrials.gov/show/NCT03558594 |
Recruiting |
VA Puget Sound Health Care System |
2020-07-28 |
| NCT03455023 |
Individualized Pharmaceutical-care for Inpatients With Cancer Pain |
https://ClinicalTrials.gov/show/NCT03455023 |
Recruiting |
Zhejiang Cancer Hospital |
2019-06-30 |
| NCT03439904 |
Individualized Pharmaceutical-care in Outpatients With Cancer Pain |
https://ClinicalTrials.gov/show/NCT03439904 |
Recruiting |
Zhejiang Cancer Hospital |
2019-06-30 |
| NCT01165281 |
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain |
https://ClinicalTrials.gov/show/NCT01165281 |
Completed |
Janssen Research & Development, LLC |
2012-08-31 |
| NCT01043068 |
The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study |
https://ClinicalTrials.gov/show/NCT01043068 |
Completed |
National Cancer Center, Korea |
2010-12-31 |
| NCT00929188 |
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain |
https://ClinicalTrials.gov/show/NCT00929188 |
Completed |
Janssen Research & Development, LLC |
2015-01-31 |
| NCT00879775 |
Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain |
https://ClinicalTrials.gov/show/NCT00879775 |
Completed |
Korea Research Foundation |
2009-07-31 |
| NCT00804076 |
Gene Transfer for Cancer Pain |
https://ClinicalTrials.gov/show/NCT00804076 |
Completed |
Diamyd Inc |
2010-11-30 |
| NCT03176199 |
A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain |
https://ClinicalTrials.gov/show/NCT03176199 |
Completed |
Taiwan Mundipharma Pharmaceuticals Ltd. |
2018-12-31 |
| NCT03641222 |
Group Versus Individual Acupuncture for Cancer Pain |
https://ClinicalTrials.gov/show/NCT03641222 |
Completed |
University of Calgary |
2018-08-30 |
| NCT00771199 |
An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain |
https://ClinicalTrials.gov/show/NCT00771199 |
Completed |
Janssen-Cilag Ltd. |
2008-11-30 |
| NCT00766831 |
An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain |
https://ClinicalTrials.gov/show/NCT00766831 |
Completed |
Janssen Korea, Ltd., Korea |
2010-06-30 |
| NCT00725114 |
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain |
https://ClinicalTrials.gov/show/NCT00725114 |
Completed |
Wex Pharmaceuticals Inc. |
2012-11-30 |
| NCT00708019 |
Improving Cancer Pain Management Through Self-Care |
https://ClinicalTrials.gov/show/NCT00708019 |
Completed |
University of California, San Francisco |
2012-12-31 |
| NCT00684632 |
A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients |
https://ClinicalTrials.gov/show/NCT00684632 |
Completed |
Kyowa Kirin Co., Ltd. |
2009-04-30 |
| NCT00683995 |
A Phase III Clinical Study of KW-2246 |
https://ClinicalTrials.gov/show/NCT00683995 |
Completed |
Kyowa Kirin Co., Ltd. |
2009-07-31 |
| NCT00676936 |
Corticosteroids for Cancer Pain |
https://ClinicalTrials.gov/show/NCT00676936 |
Completed |
Norwegian University of Science and Technology |
2012-02-29 |
| NCT00675948 |
Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain |
https://ClinicalTrials.gov/show/NCT00675948 |
Completed |
GW Pharmaceuticals Ltd. |
2006-09-30 |
| NCT00644787 |
A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain |
https://ClinicalTrials.gov/show/NCT00644787 |
Completed |
Janssen Pharmaceutical K.K. |
2008-10-31 |
| NCT00641667 |
An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain |
https://ClinicalTrials.gov/show/NCT00641667 |
Completed |
Janssen Pharmaceutical K.K. |
2008-06-30 |
| NCT00576017 |
A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs). |
https://ClinicalTrials.gov/show/NCT00576017 |
Completed |
Janssen-Cilag, S.A. |
NA |
| NCT00538863 |
Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain |
https://ClinicalTrials.gov/show/NCT00538863 |
Completed |
INSYS Therapeutics Inc |
2010-10-31 |
| NCT00538850 |
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain |
https://ClinicalTrials.gov/show/NCT00538850 |
Completed |
INSYS Therapeutics Inc |
2010-02-28 |
| NCT00513656 |
A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain |
https://ClinicalTrials.gov/show/NCT00513656 |
Completed |
Mundipharma Research GmbH & Co KG |
2010-03-31 |
| NCT00484484 |
Ketamine Associated With Opioids in Refractory Cancer Pain Treatment |
https://ClinicalTrials.gov/show/NCT00484484 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2009-09-30 |
| NCT00472303 |
A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine |
https://ClinicalTrials.gov/show/NCT00472303 |
Completed |
Grünenthal GmbH |
2012-06-30 |
| NCT00459277 |
Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids |
https://ClinicalTrials.gov/show/NCT00459277 |
Completed |
Archimedes Development Ltd |
2008-07-31 |
| NCT00411034 |
A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain |
https://ClinicalTrials.gov/show/NCT00411034 |
Completed |
Alza Corporation, DE, USA |
NA |
| NCT00410787 |
Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain |
https://ClinicalTrials.gov/show/NCT00410787 |
Completed |
Alza Corporation, DE, USA |
NA |
| NCT00410540 |
A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients. |
https://ClinicalTrials.gov/show/NCT00410540 |
Completed |
Alza Corporation, DE, USA |
NA |
| NCT00401063 |
Usefulness of Acupuncture in Cancer Pain and Quality of Life |
https://ClinicalTrials.gov/show/NCT00401063 |
Completed |
Southern California University of Health Sciences |
2007-08-31 |
| NCT00378937 |
Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain |
https://ClinicalTrials.gov/show/NCT00378937 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00355628 |
Clinical Study of KW-2246 in Patients With Cancer Pain |
https://ClinicalTrials.gov/show/NCT00355628 |
Completed |
Kyowa Kirin Co., Ltd. |
2007-07-31 |
| NCT00283166 |
Coaching to Improve Care of Cancer Pain |
https://ClinicalTrials.gov/show/NCT00283166 |
Completed |
University of California, Davis |
2009-03-31 |
| NCT00279344 |
Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN) |
https://ClinicalTrials.gov/show/NCT00279344 |
Completed |
Nycomed |
NA |
| NCT00216658 |
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics - |
https://ClinicalTrials.gov/show/NCT00216658 |
Completed |
Janssen Pharmaceutical K.K. |
NA |
| NCT00152854 |
Acetaminophen for Cancer Pain |
https://ClinicalTrials.gov/show/NCT00152854 |
Completed |
University Health Network, Toronto |
2012-12-31 |
| NCT00136669 |
Acupuncture For Pancreatic Cancer Pain |
https://ClinicalTrials.gov/show/NCT00136669 |
Completed |
Memorial Sloan Kettering Cancer Center |
NA |
| NCT00135577 |
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects |
https://ClinicalTrials.gov/show/NCT00135577 |
Completed |
Cubist Pharmaceuticals LLC |
2007-04-30 |
| NCT00012896 |
Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines |
https://ClinicalTrials.gov/show/NCT00012896 |
Completed |
VA Office of Research and Development |
NA |